[20] Our study clearly demonstrates that at an average of 2 years of follow-up after SVG stent implant in 89 consecutive patients, only 28% of patients experienced an event-free survival.
Premature discontinuation of antiplatelet therapy is the most important predictor of stent thrombosis; therefore, patients who are candidates for implantation of drug-eluting stents should be ...
The impact of overlap of drug-eluting stents on clinical and angiographic outcomes is controversial. Individuals with long coronary lesions requiring implantation of multiple stents are an ...
A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation, 1996; 93: 215–22.
A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation, 1996; 93: 215–22.
Rockville, MD, Oct. 28, 2024 (GLOBE NEWSWIRE) -- The global peripheral stent implant market is set to be valued at US$ 4.11 billion in 2024 and is projected to expand at 6.6% CAGR from 2024 to 2034.
Rockville, MD, Oct. 28, 2024 (GLOBE NEWSWIRE) -- The global peripheral stent implant market is set to be valued at US$ 4.11 billion in 2024 and is projected to expand at 6.6% CAGR from 2024 to 2034.
People who've survived a heart attack and have been given a stent may be better off quitting low-dose aspirin a month after the procedure, a new study finds. The strategy is "beneficial by ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
For patients with severely calcified coronary lesions, routine treatment with orbital atherectomy prior to drug-eluting stent implantation does not yield greater minimal stent area or reduce the ...